Aplastic Anemia Home
Navigation Page
New Forum Available

 Old Forum Data Only

FREE Aplastic Book Preview
 
 


If aplasticcentral has helped you, please help me.
          
          Web Site 
Start Here Aplastic Anemia Basics Acronyms Site Listing Don't Quit BLOG Bruce Story
AA White Paper Short List Medical Dictionary Social Security  Alternative Wellness Aplastic BLOG
Archived AA Forums Archived Patient Stories LINKS Transplants Bone Marrow Disorders Email Bruce
Clinical Trials Medic Alert Patient Stories Add Your Story Nat'l Inst of Health Nutrition

Aplastic Central MDS Patient Conference Trip Report- WIP

Sue (my wife), Melissa (my daughter) and I attended the AA/MDS International Foundation Patient Conference in St. Louis from Friday July 27 to Sunday July 29.  Here is a "trip report" on our experience. There were approximately 250 people in attendance including AA/MDS/PNH patients and their families.  We met lots of people and had the opportunity to listen to many well informed medical professionals who provided good information on the current state of the art.  

Friday - July 27

Friday was a bit of a disappointment.  A scheduled session for reviewing "Research the Internet" was overflowing and we were unable to even get in the room.  Did not appear to be of much use to us since we are professional surfers, but I assume others may have learned a few things.

In the next session for patients we were told not to discuss our personal stories by a 30 something who added very little value.  We were to discuss our "coping strategies".  Most everyone in the group seemed to be coping well and we could have used the hour much more constructively.  I will be sending my suggestions to Marilyn who seemed anxious to hear my thoughts when I expressed disappointment in Friday.   

The concept was to split AA and MDS into two separate groups, spouses to another and  family members to another.  Feedback on all sessions was not very good.  We then got back together with family members and had a free for all that also seemed of little or no value.  There needed to be more structure for people who did not know what to expect, did not know each other and were wondering what was going on.  

The evening brought a rather disorganized dinner of pressed turkey that was inedible preceded by two excellent speaker and one marginal speaker.  We really enjoyed a talk by Dr. David Biro who is an MD who also suffered from AA/PNH.  His talk was inspiring as he described how he beat the illness with a matched sibling donor BMT.  He authored a book called One Hundred Days which I highly recommend (See Booklist) . In a down to earth, factual, often frightening and humorous manner, Dr. Biro describes the hell he went through during full body irradiation in which they kill all your bone marrow and completely wipe out your immune system.  David's talk salvaged an otherwise marginal day.

Saturday - July 28

Completely turned around from Saturday.  The speakers were all MD's and they provided great insight on their chosen topics.  There was always adequate time for Q&A and the questions were almost always high quality and answered very well.  They split one big room into two smaller ones and ran two concurrent sessions - one for AA and one for MDS.  Except for one exception, Sue, Melissa and I attended all AA sessions.  We unfortunately missed most of the 8:15 session on Iron Overload Management but managed to pick up the gist of the talk from Q&A.  Dr. Eric Nisbet-Brown of Dana Farber discussed the protocol for iron chelation (reducing the amount of iron in your system after multiple red blood cell transfusions).  The drug of choice is desferol.  To quote Dr. Nisbet-Brown, "chronic red blood cell transfuions lead to accumulation of excess iron in various tissues of the bodyu, including the liver, the heart and the pituitary, because the body lacks mechanisms for effectively secreting iron. Iron deposited ... in organs may cause significant harm.  At present, the only iron-chelating drug licensed in North America is deferoxamine (Desferal) whichi is generally given as a slo subcutaneous infusion using a portable infusion pump...Orally-active iron chelators remain an area of active research, but none has yet been licensed in North America.

Our next session was presented by Dr. Lucio Luzzatto, the world expert on PNH - Paroxysmal nocturnal hemoglobinuria (PNH).  His topic was "Non-Transplant Treatments for AA" He confirmed ATG/ALG plus Cyclosporine as the recommended first line treatment for AA patients who do not have a sibling matched donor.  There was not really anything new discussed as this protocol has been around for quite awhile.  It was my first exposure to PNH which is a rare and strange disorder linked to AA.  Patients with PNH have the added risk/benefit of premature clotting or venous thrombosis (abnormal clotting) in addition to thrombochytopenia (low platelets) and neutorpenia (low white cell counts).

The next speaker was Richard Champlin of M.D. Anderson Cancer Center in Texas.  He discussed "Recent Advances in Therapy for AA". He began by stating that Bone Marrow is "the largest organ in the body" and explained the function of bone marrow and each of the blood cells.  He described the stem gell generation process and then got into the details of the disease.   He mentioned ATG/Cyclosporine and Colony Stimulating Factors including G-CSF which stiulates granulocyte production, erythroprotein to stimulate red cells, and interleukin-11 for platelets.  (Note - I am currently receiving all of the above and have not responded to anything after over seven months).  He went on to discuss the current strategies for transplants.  He stated that "Since GVHD (Graft vs Host Disease) is the major cause of morbidity and mortality, transplantation of bone marrow should be preferred over blood stem cells. Graft rejection is a major concern with BMT."  Intensification of the preparative regimen has reduced GVHD but increases the risk of mortality from other other causes.  i.e. cancer, liver problems, infections, etc.  The latest strategy is to include a drug called fludarabine which in some cases has provided a less toxic enrironment.  (My translpant strategy would include fludarabine).  I loved the closing on his speaker abstract and I quote:  " For patients without a matched sibling or older patients (age>50 years), immunomodulatory treatment with ATG/cyclosporine should be administered"  Leaving me with the obvious conclusion that since I am over 50 (now considered old!) and have not responded to ATG that I am in a world of trouble!

I skipped the session on Pediatric Treatments for AA but have the abstract if anyone is interested.  Send me an email and I'll transcribe it for you.  

The absolute best part of the whole session came next - Wide open Q&A with a doctor panel - Four of five docs responding to questions from the patients and families.  The answers were precise, thoughtful and when they didn't know they admitted it and did their best to formulate a meaningful response.  Some that I remember:

Q. I have been in remission for nearly two years, my platelet count is low (20,000) but everything else is normal and I am transfusion independent.  What, it anything should I be doing?

A. Avoid sharp objects.  Otherwise you are fine and in good shape.

Q. - Many questions on PNH during which I tuned out.  As far as I know, I don't have it and can't deal with anymore bad news right now - thank you very much.

Q. What are ramifications/side effects of cyclosporine?

A. Potential kidney damage - Be sure to stay well hydrated.  High blood pressure - Monitor - medication available. Lowered magnesium level - take supplemental magnesium with guidance from caretaker.

  More to come when I get time.........

 

 

Respectfully submitted.

Bruce Lande

 
 


 If aplasticcentral has helped you with aplastic anemia, please consider making a donation.  Thanks!  Bruce